ello, everyone, and how are you today? We are just fine, thank you, especially with a shiny sun warming the oh-so-quiet Pharmalot campus. The short person has left for the local schoolhouse, the official mascots are snoozing in distant corners, and we are brewing more cups of stimulation in the coffee kettle. All of this means we are getting ready to attack the to-do list. No doubt, you can relate. So here are some tidbits to get you going. Hope you have a smashing day and do stay in touch …

Alexion Pharmaceuticals (ALXN) is cutting 20 percent of its workforce, or about 600 employees, as part of a reorganization to save $270 million in annual costs. The drug maker, which recently overhauled management, is moving to Boston from New Haven, Conn., but its research center will remain. Alexion, which is being investigated by authorities, was caught in a scandal in which employees were pressured to convince customers to order drugs to meet financial goals.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.